Latest News
The Role of the Pharmacist after Dobbs v. Jackson Women’s Health Organization Ruling
The Hematology/Oncology Pharmacy Association (HOPA) is committed to optimizing cancer care for all individuals. The recent U.S. Supreme Court decision, which overturned Roe v. Wade, imposes a significant barrier to the oncology community’s ability to ens
National Survey on the Effect of Oncology Drug Shortages in Clinical Practice: A Hematology Oncology Pharmacy Association Survey
Oncology drug shortages often result in disruptions in the timing of chemotherapy treatments, alterations in the dose or regimen administered, or even missed doses when alternative agents are unavailable. The purpose of this survey was to characterize the
The Role of the Pharmacist after Dobbs v. Jackson Women’s Health Organization Ruling
The Hematology/Oncology Pharmacy Association (HOPA) is committed to optimizing cancer care for all individuals. The recent U.S. Supreme Court decision, which overturned Roe v. Wade, imposes a significant barrier to the oncology community’s ability to ens
Streamfield variant - default Image. Lorem ipsum dolor sit amet consectetur. Accumsan rutrum egestas ultrices.
Lorem ipsum dolor sit amet consectetur. Mauris nisi pulvinar sem pharetra maecenas egestas aenean tortor. Cras vulputate sem volutpat libero. Duis nec augue laoreet in odio est malesuada ut facilisi. Feugiat mauris lorem sed pellentesque mauris et et. In
Learn More
Streamfield variant - default Image. Lorem ipsum dolor sit amet consectetur. Accumsan rutrum egestas ultrices.
Streamfield variant - Banner (larger) image. Lorem ipsum dolor sit amet consectetur.
Learn More
Streamfield variant - no image, centered text. Lorem ipsum dolor sit amet consectetur. Accumsan rutrum egestas ultrices.
Lorem ipsum dolor sit amet consectetur. Lacus tristique et integer nulla vitae cursus nunc vel. Eget quam lobortis sit diam porttitor velit. Ut velit dignissim turpis neque lectus duis nibh. Nibh tellus sodales odio urna.
Learn MoreLatest News
Pharmacy Students and Oncology Pharmacists Combat Cancer Misinformation with National Initiative
The Hematology/Oncology Pharmacy Association (HOPA) is proud to team up with the Student National Pharmaceutical Association (SNPhA) for the Cancer Clarity Challenge, a new national competition.
Pharmacist's Application to Practice: Taletrectinib
Benjamin Pastore, PharmD, PGY2 Adult Oncology Pharmacy Resident, and Jasmine Patel, PharmD, BCOP, Clinical Pharmacy Specialist - Thoracic Oncology, discuss the potential role of taletrectinib in the treatment of metastatic non-small cell lung cancer.
Pharmacist's Application to Practice: Zongertinib
Reyam Katchi, PharmD, PGY2 Hematology/Oncology Pharmacy Resident, and Kiera Roubal, PharmD, Oncology Clinical Pharmacist, break down the potential role for zongertinib in the treatment of non-squamous NSCLC with HER2 TKD activating mutations.
Late-Breaking HOPA News: NeoADAURA: Advancing Neoadjuvant Osimertinib for Resectable EGFR-Mutated NSCLC
Wai Tak Vince Sung, PharmD, MBA, BCOP, BCSCP, breaks down the results from the NeoADAURA trial and what its findings may mean for neoadjuvant osimertinib's role in the treatment of resectable EGFR-mutated NSCLC.
Proposed Student Loan Limits for Nursing and Other Professions Will Contribute to Healthcare Worker Shortages
HOPA is concerned about the Department of Education's proposed language and student loan limits for professions crucial to oncology care, especially nursing. Implementation will contribute to the shortage of healthcare workers in this country.
Explore more from HOPA
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
The data from this trial confirm that FTD–TPI plus bevacizumab is an effective treatment option for patients with refractory metastatic colorectal cancer, irrespective of mutational status, which side the tumor is on, and whether patients have previously
